Association Between Frailty or Sarcopenia and Adverse Outcomes in Inflammatory Bowel Disease: A Systematic Review

Overview

Journal Gastro Hep Adv

Specialty Gastroenterology

Date 2024 Aug 12

PMID 39131118

Authors

Katherine Bedard

Naheed Rajabali

Puneeta Tandon

Juan G Abraldes

Farhad Peerani

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Chronological age often guides the management of patients with inflammatory bowel disease (IBD). Frailty and sarcopenia, which are related but distinct entities that become increasingly prevalent with age, better predict nonsurgical and surgical outcomes in various chronic illnesses. We conducted a systematic review to assess the association between frailty or sarcopenia and adverse nonsurgical outcomes in adult patients with IBD.

Methods: Through a systematic literature review of 4 online databases (MEDLINE, EMBASE, Scopus, and CINAHL Plus), we identified 16 studies that focused on frailty or sarcopenia and nonsurgical outcomes in IBD. The Newcastle-Ottawa Scale was used to determine the quality of included studies.

Results: We identified 16 studies: 8 frailty-based and 8 sarcopenia-based studies (14 high-quality and 2 low-quality studies). All results were presented in a summarized narrative format. Frailty predicted all hospitalization-related outcomes (hospitalization, readmission, and length of stay) and mortality-related outcomes. The outcomes of therapeutic efficacy, need for therapy escalation, and infections had mixed results in relation to their association with frailty or sarcopenia. The data regarding sarcopenia and hospitalizations were also equivocal.

Conclusion: This systematic review supports the use of frailty indices to predict hospitalization- and mortality-related outcomes in adult patients with IBD. Future research should focus on identifying and validating frailty and sarcopenia tools in IBD to better help predict adverse clinical outcomes and response to therapy.

Citing Articles

Handgrip strength and risk of malnutrition are associated with an increased risk of hospitalizations in inflammatory bowel disease patients.

Bedard K, Taylor L, Rajabali N, Kroeker K, Halloran B, Meng G Therap Adv Gastroenterol. 2023; 16:17562848231194395.

PMID: 37667803 PMC: 10475242. DOI: 10.1177/17562848231194395.

Managing the older adult with inflammatory bowel disease: is age just a number?.

Bermudez H, Faye A, Kochar B Curr Opin Gastroenterol. 2023; 39(4):268-273.

PMID: 37265181 PMC: 10275506. DOI: 10.1097/MOG.0000000000000943.

Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence.

Fons A, Kalisvaart K, Maljaars J J Clin Med. 2023; 12(2).

PMID: 36675461 PMC: 9860672. DOI: 10.3390/jcm12020533.

Prevalence of frailty among patients with inflammatory bowel disease and its association with clinical outcomes: a systematic review and meta-analysis.

Huang X, Xiao M, Jiang B, Wang X, Tang X, Xu X BMC Gastroenterol. 2022; 22(1):534.

PMID: 36550400 PMC: 9773593. DOI: 10.1186/s12876-022-02620-3.

Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography.

Nardone O, Ponsiglione A, De Sire R, Calabrese G, Liuzzi R, Testa A Nutrients. 2022; 14(17).

PMID: 36079718 PMC: 9458031. DOI: 10.3390/nu14173460.

References

Fearon K, Strasser F, Anker S, Bosaeus I, Bruera E, Fainsinger R . Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489-95. DOI: 10.1016/S1470-2045(10)70218-7. View

Pasqualetti G, Calsolaro V, Bernardini S, Linsalata G, Bigazzi R, Caraccio N . Degree of Peripheral Thyroxin Deiodination, Frailty, and Long-Term Survival in Hospitalized Older Patients. J Clin Endocrinol Metab. 2018; 103(5):1867-1876. DOI: 10.1210/jc.2017-02149. View

Zhang T, Cao L, Cao T, Yang J, Gong J, Zhu W . Prevalence of Sarcopenia and Its Impact on Postoperative Outcome in Patients With Crohn's Disease Undergoing Bowel Resection. JPEN J Parenter Enteral Nutr. 2015; 41(4):592-600. DOI: 10.1177/0148607115612054. View

Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(4):601. PMC: 6593317. DOI: 10.1093/ageing/afz046. View

Ananthakrishnan A, Shi H, Tang W, Law C, Sung J, Chan F . Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease. J Crohns Colitis. 2016; 10(10):1224-36. PMC: 6082591. DOI: 10.1093/ecco-jcc/jjw054. View

Bertani L, Trico D, Pugliese D, Privitera G, Linsalata G, Zanzi F . Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients. Aliment Pharmacol Ther. 2020; 53(2):273-280. DOI: 10.1111/apt.16167. View

Holt D, Varma P, Strauss B, Rajadurai A, Moore G . Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis. Eur J Clin Nutr. 2017; 71(6):773-777. DOI: 10.1038/ejcn.2017.10. View

Sze S, Pellicori P, Zhang J, Weston J, Clark A . Identification of Frailty in Chronic Heart Failure. JACC Heart Fail. 2019; 7(4):291-302. DOI: 10.1016/j.jchf.2018.11.017. View

Faye A, Colombel J . Aging and IBD: A New Challenge for Clinicians and Researchers. Inflamm Bowel Dis. 2021; 28(1):126-132. DOI: 10.1093/ibd/izab039. View

10.

Cushing K, Kordbacheh H, Gee M, Kambadakone A, Ananthakrishnan A . Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients. J Crohns Colitis. 2018; 12(9):1036-1041. PMC: 6113707. DOI: 10.1093/ecco-jcc/jjy064. View

11.

Qian A, Nguyen N, Elia J, Ohno-Machado L, Sandborn W, Singh S . Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020; 19(10):2054-2063.e14. PMC: 7930013. DOI: 10.1016/j.cgh.2020.08.010. View

12.

Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S . Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016; 46(10):951-63. DOI: 10.1111/hepr.12774. View

13.

Rockwood K, Stadnyk K, Macknight C, McDowell I, Hebert R, Hogan D . A brief clinical instrument to classify frailty in elderly people. Lancet. 1999; 353(9148):205-6. DOI: 10.1016/S0140-6736(98)04402-X. View

14.

Clegg A, Young J, Iliffe S, Rikkert M, Rockwood K . Frailty in elderly people. Lancet. 2013; 381(9868):752-62. PMC: 4098658. DOI: 10.1016/S0140-6736(12)62167-9. View

15.

Zhang T, Ding C, Xie T, Yang J, Dai X, Lv T . Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Clin Nutr. 2016; 36(6):1586-1592. DOI: 10.1016/j.clnu.2016.10.004. View

16.

Gisbert J, Chaparro M . Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice. J Crohns Colitis. 2019; 14(5):694-709. DOI: 10.1093/ecco-jcc/jjz195. View

17.

Dedhia P, White Y, Dillman J, Adler J, Jarboe M, Teitelbaum D . Reduced paraspinous muscle area is associated with post-colectomy complications in children with ulcerative colitis. J Pediatr Surg. 2017; 53(3):477-482. DOI: 10.1016/j.jpedsurg.2017.09.006. View

18.

Mourtzakis M, Prado C, Lieffers J, Reiman T, McCargar L, Baracos V . A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008; 33(5):997-1006. DOI: 10.1139/H08-075. View

19.

Nguyen T, Cumming R, Hilmer S . The Impact of Frailty on Mortality, Length of Stay and Re-hospitalisation in Older Patients with Atrial Fibrillation. Heart Lung Circ. 2016; 25(6):551-7. DOI: 10.1016/j.hlc.2015.12.002. View

20.

Rockwood K, Song X, MacKnight C, Bergman H, Hogan D, McDowell I . A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173(5):489-95. PMC: 1188185. DOI: 10.1503/cmaj.050051. View